These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 24838743)
1. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine. Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743 [TBL] [Abstract][Full Text] [Related]
2. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells. Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171 [TBL] [Abstract][Full Text] [Related]
3. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine. Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537 [TBL] [Abstract][Full Text] [Related]
4. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609 [TBL] [Abstract][Full Text] [Related]
6. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma. Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175 [TBL] [Abstract][Full Text] [Related]
7. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli. Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438 [TBL] [Abstract][Full Text] [Related]
8. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa. Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide. Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms. Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536 [TBL] [Abstract][Full Text] [Related]
11. Influence of N-acylation of a peptide derived from human lactoferricin on membrane selectivity. Zweytick D; Pabst G; Abuja PM; Jilek A; Blondelle SE; Andrä J; Jerala R; Monreal D; Martinez de Tejada G; Lohner K Biochim Biophys Acta; 2006 Sep; 1758(9):1426-35. PubMed ID: 16616888 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1. Desai TJ; Udugamasooriya DG Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795 [TBL] [Abstract][Full Text] [Related]
13. Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides. Zweytick D; Deutsch G; Andrä J; Blondelle SE; Vollmer E; Jerala R; Lohner K J Biol Chem; 2011 Jun; 286(24):21266-76. PubMed ID: 21515687 [TBL] [Abstract][Full Text] [Related]
14. Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides. Vogel HJ; Schibli DJ; Jing W; Lohmeier-Vogel EM; Epand RF; Epand RM Biochem Cell Biol; 2002; 80(1):49-63. PubMed ID: 11908643 [TBL] [Abstract][Full Text] [Related]
15. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529 [TBL] [Abstract][Full Text] [Related]
16. In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. Riedl S; Rinner B; Asslaber M; Schaider H; Walzer S; Novak A; Lohner K; Zweytick D Biochim Biophys Acta; 2011 Nov; 1808(11):2638-45. PubMed ID: 21810406 [TBL] [Abstract][Full Text] [Related]
17. Bridging the Antimicrobial Activity of Two Lactoferricin Derivatives in Marx L; Semeraro EF; Mandl J; Kremser J; Frewein MP; Malanovic N; Lohner K; Pabst G Front Med Technol; 2021; 3():625975. PubMed ID: 35047906 [TBL] [Abstract][Full Text] [Related]
18. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine. Schröder-Borm H; Bakalova R; Andrä J FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280 [TBL] [Abstract][Full Text] [Related]
19. N-acylated peptides derived from human lactoferricin perturb organization of cardiolipin and phosphatidylethanolamine in cell membranes and induce defects in Escherichia coli cell division. Zweytick D; Japelj B; Mileykovskaya E; Zorko M; Dowhan W; Blondelle SE; Riedl S; Jerala R; Lohner K PLoS One; 2014; 9(3):e90228. PubMed ID: 24595074 [TBL] [Abstract][Full Text] [Related]
20. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. Papo N; Shai Y Biochemistry; 2003 Aug; 42(31):9346-54. PubMed ID: 12899621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]